Skip to main content
. 2018 Feb 14;75(4):336–346. doi: 10.1001/jamapsychiatry.2017.4602

Table 5. Associations Between MDD Specifiers, Clinical Correlates, Treatment, and Impaired Functioning in 7432 Participants With Lifetime MDDa.

Characteristic Anxious/Distressed Specifierb Mixed-Features Specifierc
No (n = 1901) Yes (n = 5531) P Value No (n = 6235) Yes (n = 1197) P Value
Model 1d Model 2e Model 3f Model 1d Model 2e Model 3f
Age at onset of first episode, mean (SE), y 31.16 (0.35) 28.34 (0.23) <.001 <.001 <.001 29.60 (0.22) 26.11 (0.47) <.001 .009 .17
No. of lifetime episodes, mean (SE) 2.70 (0.12) 4.26 (0.13) <.001 <.001 <.001 3.69 (0.12) 4.81 (0.36) .006 .009 .09
Duration of longest or only lifetime episode, median (SE), wk 22.60 (1.19) 33.43 (2.99) .001 .002 .08 25.70 (0.12) 51.41 (0.39) .002 <.001 <.001
DSM-5 Specifiers, % (SE)
Severitya
Mild (5 symptoms) 23.53 (1.17) 6.48 (0.41) <.001 <.001 NA 12.06 (0.47) 3.93 (0.55) <.001 <.001 NA
Moderate (6-7 symptoms) 53.53 (1.25) 34.96 (0.87) 42.12 (0.80) 26.32 (1.55)
Severe (8-9 symptoms) 22.95 (1.16) 58.57 (0.90) 45.82 (0.74) 69.75 (1.61)
Anxious/distressed specifiera NA NA NA NA NA 71.29 (0.72) 92.83 (0.84) <.001 <.001 <.001
Mixed-features specifierb 4.39 (0.47) 19.32 (0.85) <.001 <.001 <.001 NA NA NA NA NA
Lifetime Treatment
Any treatment for MDD, % (SE) 61.06 (1.40) 72.27 (0.84) <.001 <.001 <.001 68.82 (0.79) 72.72 (1.83) .05 <.001 .02
Medication 42.26 (1.40) 56.80 (0.88) <.001 <.001 <.001 52.52 (0.85) 56.33 (1.92) .06 <.001 .05
Talk therapy with a professional 54.79 (1.49) 65.11 (0.92) <.001 <.001 <.001 61.99 (0.89) 65.22 (1.73) .10 <.001 .02
Nonprofessional organized support 9.87 (0.83) 16.65 (0.65) <.001 <.001 <.001 13.48 (0.55) 22.83 (1.52) <.001 <.001 <.001
Emergency department 5.06 (0.61) 11.88 (0.62) <.001 <.001 <.001 9.07 (0.46) 16.02 (1.38) <.001 <.001 .001
Hospitalized overnight or longer 6.23 (0.63) 13.75 (0.58) <.001 <.001 <.001 10.60 (0.49) 18.60 (1.41) <.001 <.001 <.001
Age at first MDD treatment, mean (SE), y 33.74 (0.48) 31.46 (0.34) <.001 <.001 .008 32.56 (0.29) 29.02 (0.62) <.001 .04 .17
Duration from onset to first treatment, mean (SE), mo 41.36 (3.83) 49.37 (1.73) .06 .09 .31 46.27 (1.83) 54.02 (4.28) .11 .04 .07
Suicidality, % (SE)a
Thought a lot about one’s own death 19.97 (1.14) 39.82 (0.87) <.001 <.001 <.001 31.55 (0.80) 52.36 (1.58) <.001 <.001 <.001
Wanted to die 31.39 (1.45) 51.95 (1.08) <.001 <.001 .07 43.82 (0.91) 62.59 (1.76) <.001 <.001 <.001
Thought a lot about suicide 25.90 (1.23) 43.87 (0.96) <.001 <.001 .02 36.85 (0.83) 52.68 (1.77) <.001 <.001 .002
Attempted suicide 6.27 (0.74) 16.12 (0.70) <.001 <.001 <.001 11.97 (0.64) 22.59 (1.52) <.001 <.001 <.001
SF-12v2 Score, Mean (SE)
Mental health 49.14 (0.31) 45.58 (0.19) <.001 <.001 <.001 46.93 (0.17) 44.05 (0.45) <.001 <.001 .006
Social functioning 49.55 (0.31) 45.82 (0.20) <.001 <.001 <.001 47.39 (0.19) 43.41 (0.42) <.001 <.001 <.001
Role-emotional functioning 47.72 (0.25) 44.20 (0.18) <.001 <.001 <.001 45.71 (0.18) 41.73 (0.42) <.001 <.001 <.001
Mental component summary 48.70 (0.29) 44.86 (0.17) <.001 <.001 <.001 46.40 (0.16) 42.75 (0.44) <.001 <.001 <.001

Abbreviations: MDD, major depressive disorder; NA, not applicable; SF-12v2, version 2 of the 12-Item Short Form Health Survey.

a

Dichotomous row variables were modeled with logistic regression. Continuous row variables were modeled with linear or log-linear regression.

b

During the lifetime episode when mood or anhedonia was at its worst.

c

Mixed features do not meet full criteria for either mania or hypomania and could characterize any MDD episode.

d

Crude association.

e

Controls for sociodemographic variables (sex, race/ethnicity, age, marital status, educational level, family income, urbanicity, and region).

f

Controls for sociodemographic variables (sex, race/ethnicity, age, marital status, educational level, family income, urbanicity, and region) and severity (mild, moderate, or severe).